US-Mexico reach preliminary NAFTA deal; agriculture biotechnology given top priority

2018-08-30 06:38:48

The modernized agreement will include 21st century agriculture biotechnology not addressed in the original NAFTA or Trans-Pacific Partnership.By Team ABLEAfter a year of ongoing negotiations, the United States and Mexico reached a preliminary agreement on a revamped North American Free Trade Agreement on Monday, Aug. 27. If Canada can reach a similar agreement, a finalized updated NAFTA may be wit

Read more

EU, India forge ties on influenza vaccine development

2018-08-30 06:37:41

EU and the Department of Biotechnology (DBT), government of India, have committed approximately Rs 120 crore each to fund this joint call.By Team ABLEThe European Union (EU) and India, on August 30, 2018, have entered into a collaboration in research and innovation to develop a next-generation influenza vaccine to protect citizens worldwide.An official from the Office of EU in India had said that,

Read more

Laurus Labs gets USFDA nod for diabetes drug

2018-08-30 06:36:08

The company has received approval from United States Food and Drug Administration (USFDA) for Bristol-Myers Squibb’s diabetes drug equivalent Metformin hydrochloride tablets.By Team ABLELaurus Labs has announced that the company has received approval from the US health regulator for its Metformin hydrochloride tablets used for treatment of diabetes.The company has received approval from United S

Read more

FDA launches Complex Innovative Designs Pilot Program to ease clinical trial simulations

2018-08-30 06:34:52

CID refers to complex adaptive, Bayesian, and other novel designs, with a focus on designs for which simulations are necessary to evaluate the clinical trial properties (e.g. power, type I error probability, etc).By Team ABLEThe US FDA on Monday August 28, 2018, has launched a pilot meeting program for complex innovative designs (CID) in a Federal Register notice titled, “Complex Innovative Desi

Read more

UN to hold High-Level Meeting on tuberculosis on September 26th; PLOS special issue calls for research papers

2018-08-29 07:27:24

This is United Nations General Assembly’s first-ever high-level meeting on tuberculosis (TB) to accelerate efforts in ending TB. The theme of the meeting is “United to end tuberculosis: an urgent global response to a global epidemic”.By Team ABLEThe Heads of State will gather in New York on 26 September, 2018, at the United Nations General Assembly first-ever high-level meeting on tuberculos

Read more

TB Alliance initiates SimpliciTB clinical trial

2018-08-29 07:25:33

This new pivotal trial examines potential of BPaMZ regimen to shorten treatment for tuberculosis and multi drug-resistant tuberculosis.By Team ABLETB Alliance has initiated a pivotal clinical trial, SimpliciTB (pronounced: sim-plis-i-tee-bee), that will evaluate whether a new four-drug regimen can treat most types of tuberculosis (TB) including multidrug-resistant TB (MDR-TB) more quickly and effe

Read more

San Diego researchers to test novel drug combination against toughest breast cancers

2018-08-28 08:32:21

Researchers at University of California San Diego School of Medicine have launched a phase Ib clinical trial to assess the safety and tolerability of cirmtuzumab, in combination with standard chemotherapy, to treat metastatic or locally advanced breast cancer that cannot be surgically removed.By Team ABLEResearchers at University of California San Diego School of Medicine have launched a phase Ib

Read more

Panacea Biotec inks tripartite agreement with Natcoand Breckenridge Pharmaceutical

2018-08-28 08:31:12

Panacea has entered into a tripartite agreement with Natco Pharma and Breckenridge Pharmaceutical for the manufacture and supply of Azacitidine injection for the U.S. market.By Team ABLEPanacea Biotec, one of the India\'s leading research based pharmaceutical and biotechnology companies, has entered into a tripartite agreement with Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc. for the man

Read more

US FDA approves AbbVie’s Imbruvica plus Rituximabindication for rare type of blood cancer

2018-08-28 08:30:28

With this approval, the IMBRUVICA prescribing information now includes combination use with rituximab, representing the first and only chemotherapy-free combination treatment specifically indicated for Waldenström\'s macroglobulinemia. By Team ABLEAbbVie, the research-based global biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has approved its IMBRU

Read more

TNAU to set up Centre of Excellence in Agri biotech at Coimbatore

2018-08-28 08:29:36

The CoE will be a joint venture between the State Government, National Bank for Agriculture and Rural Development (NABARD), TNAU, private industries and philanthropists.By Team ABLETamil Nadu Agricultural University (TNAU), located at Coimbatore, is going to set up a Centre of Excellence in Biotechnology to promote research in agriculture biotechnology.The press release by the university says that

Read more